Hinge Health, Inc. Class A (HNGE) Price & Analysis

Compare

121 Followers

HNGE Stock Chart & Stats

Day’s Range― - ―

52-Week Range$33.42 - $62.18

Previous Close$36.79

Volume525.07K

Average Volume (3M)738.54K

Market Cap

$4.32B

Enterprise Value$3.84B

Total Cash (Recent Filing)$413.26M

Total Debt (Recent Filing)$9.97M

Price to Earnings (P/E)27.7

Beta2.33

Next Earnings

Aug 05, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding27,223,448

10 Day Avg. Volume764,834

30 Day Avg. Volume738,544

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.89

Enterprise Value/Revenue14.60

Enterprise Value/Gross Profit19.39

Enterprise Value/Ebitda-6.85

Forecast

1Y Price Target

$58.85

Price Target Upside6.73% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering14

Bulls Say, Bears Say

Bulls Say

Financial PerformanceHinge posted a strong gross profit margin of over 80% in recent quarters, showing sustainability through efficiency gains and controlled distribution of the Enso electrostimulation device.

Market ExpansionThe company also expanded its global presence to five European countries, further expanding its total addressable market.

Revenue GrowthManagement raised FY revenue guidance to 41% y/y growth on sustaining yield improvements and eligible lives momentum in addition to an expected strong 2H sales cycle and further penetration of new segments.

Bears Say

Cost ManagementSavings from the curated network will be up to 50%, though average savings will likely fall well below the 50% level.

Partnership RelianceKey risks for Hinge Health include reliance on key distribution partners such as health plans and PBMs.

Hinge Health, Inc. Class A News

Hinge Health falls -8.5%

Hinge Health (HNGE) is down -8.5%, or -$5.03 to $54.00. Published first on TheFly – the ultimate source...

10d ago

HNGE

Hinge Health price target raised to $65 from $45 at Raymond James

Raymond James raised the firm’s price target on Hinge Health (HNGE) to $65 from $45 and keeps an...

23d ago

HNGE

Hinge Health price target raised to $59 from $47 at Needham

Needham raised the firm’s price target on Hinge Health (HNGE) to $59 from $47 and keeps a Buy...

23d ago

HNGE

Hinge Health price target raised to $62 from $48 at Truist

Truist raised the firm’s price target on Hinge Health (HNGE) to $62 from $48 and keeps a Buy...

23d ago

HNGE

Hinge Health price target raised to $63 from $55 at Stifel

Stifel analyst David Grossman raised the firm’s price target on Hinge Health (HNGE) to $63 from $55 and...

23d ago

HNGE

Video: Disney, McDonald’s and Uber headline busy earnings slate

The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how...

23d ago

AMD

DIS

Hinge Health price target raised to $64 from $42 at BofA

BofA raised the firm’s price target on Hinge Health (HNGE) to $64 from $42 and keeps a Buy...

23d ago

HNGE

Hinge Health price target raised to $57 from $46 at Morgan Stanley

Morgan Stanley analyst Craig Hettenbach raised the firm’s price target on Hinge Health (HNGE) to $57 from $46...

23d ago

HNGE

Hinge Health price target raised to $61 from $52 at Canaccord

Canaccord raised the firm’s price target on Hinge Health (HNGE) to $61 from $52 and keeps a Buy...

23d ago

HNGE

Hinge Health reports Q2 EPS ($13.10) vs (96c) last year

Reports Q2 revenue $139.1M, consensus $125.34M. “In Q2 we delivered year-over-year revenue growth of 55% and a strong...

23d ago

HNGE

Hinge Health’s Strategic Initiatives and Growth Potential Drive Buy Rating

Canaccord Genuity analyst Richard Close maintained a Buy rating on Hinge Health, Inc. Class A yesterday and set...

15d ago

HNGE

Hinge Health Announces Early Share Lock-Up Release

Hinge Health, Inc. Class A ( ($HNGE) ) just unveiled an announcement. Hinge Health, Inc. recently completed its...

15d ago

HNGE

Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald

Needham analyst Ryan MacDonald maintained a Buy rating on Hinge Health, Inc. Class A today and set a...

22d ago

HNGE

Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective

Analyst Bradley Sills of Bank of America Securities reiterated a Buy rating on Hinge Health, Inc. Class A,...

22d ago

HNGE

HNGE FAQ

What was Hinge Health, Inc. Class A’s price range in the past 12 months?

Hinge Health, Inc. Class A lowest stock price was $33.42 and its highest was $62.18 in the past 12 months.

What is Hinge Health, Inc. Class A’s market cap?

Hinge Health, Inc. Class A’s market cap is $4.32B.

When is Hinge Health, Inc. Class A’s upcoming earnings report date?

Hinge Health, Inc. Class A’s upcoming earnings report date is Aug 05, 2025 which is 24 days ago.

How were Hinge Health, Inc. Class A’s earnings last quarter?

Hinge Health, Inc. Class A released its earnings results on Aug 05, 2025. The company reported $0.349 earnings per share for the quarter, beating the consensus estimate of $0.086 by $0.263.

Is Hinge Health, Inc. Class A overvalued?

According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Hinge Health, Inc. Class A pay dividends?

Hinge Health, Inc. Class A does not currently pay dividends.

What is Hinge Health, Inc. Class A’s EPS estimate?

Hinge Health, Inc. Class A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hinge Health, Inc. Class A have?

Hinge Health, Inc. Class A has 27,223,448 shares outstanding.

What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?

Hinge Health, Inc. Class A reported an EPS of $0.349 in its last earnings report, beating expectations of $0.086. Following the earnings report the stock price went up 25.57%.

Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?

Currently, no hedge funds are holding shares in HNGE

Hinge Health, Inc. Class A Stock Smart Score

Outperform

Company Description

Hinge Health, Inc. Class A

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

Hinge Health, Inc. Class A (HNGE) Earnings & Revenues

Historic Earnings Reports

HNGE Company Deck

HNGE Earnings Call

Q2 2025

0:00 / 0:00

HNGE Stock 12 Month Forecast

Average Price Target

$58.85

▲(6.73% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","47":"$47","55":"$55","63":"$63","71":"$71"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":70,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$70.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":58.85,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$58.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":45,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$45.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,47,55,63,71],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,46.87692307692308,48.80384615384616,50.73076923076923,52.65769230769231,54.58461538461539,56.511538461538464,58.43846153846154,60.36538461538461,62.292307692307695,64.21923076923076,66.14615384615385,68.07307692307693,{"y":70,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,46.019230769230774,47.088461538461544,48.15769230769231,49.22692307692308,50.29615384615385,51.36538461538462,52.434615384615384,53.503846153846155,54.573076923076925,55.642307692307696,56.71153846153847,57.78076923076924,{"y":58.85,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,44.95384615384616,44.95769230769231,44.96153846153847,44.965384615384615,44.96923076923077,44.973076923076924,44.97692307692308,44.98076923076923,44.98461538461539,44.988461538461536,44.99230769230769,44.996153846153845,{"y":45,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":40.16,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >